Woburn, MA 4/1/08—BioTrove, a supplier of microfluidic-based laboratory instruments for genomic analysis, has filed with the SEC for an IPO of its common stock on the NASDAQ exchange. Pricing and timing details are yet to be determined. The company sells the Open Array system for multiplex PCR analysis in research and diagnostic applications, and the […]
Bothell, WA 3/27/08—In conjunction with its plan to merge with integrated circuits supplier GigOptix, Lumera has announced that operations of Plexera Biosciences, its life science instrument subsidiary, will cease immediately. Publicly held Lumera will merge its Electro-Optics segment with GigOptix, thereby taking GigOptix public. Lumera Chairman C. James Judson stated: “[W] e do not have […]
London, UK 2/26/08 and 3/31/08—X-ray metrology firm Bede has appointed BDO Soy Hayward as joint administrators for the company. Bede stated it also expects no return to equity shareholders. On February 26, the company announced that discussions with possible bidders had been terminated and that it was suspending the trading of its stock on the […]
Cambridge, MA and Bothell, WA 3/31/08—Synthetic biology firm Codon Devices and Blue Heron Biotechnology, a provider of gene synthesis services, have settled their legal dispute stemming from Codon’s 2007 suit against Blue Heron. The suit alleged infringement of four patents owned by Duke University (US Patent Nos. 5,459,039; 5,556,750; 5,679,522; and 5,702,894) and one MIT […]
Waltham, MA 3/31/08—PerkinElmer has acquired LabMetrix Technologies, a provider of metrology-based multivendor analytical instrument qualification solutions. Terms were not disclosed. In 2007, LabMetrix generated revenues of approximately $5 million. “This acquisition expands our support of customers in regulated markets by combining metrology-based multivendor qualification solutions with PerkinElmer’s existing services capabilities,” commented PerkinElmer President and CEO […]
Jena, Germany 3/31/08—Analytik Jena AG has signed a contract to sell 51% of its project business, AJZ Engineering GmbH, to AJZ Engineering’s management for €0.9 million ($1.2 million). In addition, the parties entered into a cooperation agreement under which Analytik Jena will secure credit for ongoing projects on a case-by-case basis. Over three to five […]
Darmstadt, Germany 2/29/08—Merck KGaA has acquired SeQuant AB, a developer of silican-gel and polmer-based sorbents for ZIC-HILIC (zwitterionic hydrophilic interaction chromatography). SeQuant has joined Merck’s Performance & Life Science Chemicals division. “[SeQuant] offers Merck superb opportunities for the future expansion of the chromatography business,” stated Klaus Bischoff, head of Merck Performance & Life Science Chemicals. […]
Hopkinton, MA and San Diego, CA 2/26/08—Caliper Life Sciences has entered into a settlement agreement with AntiCancer, resolving the patent infringement suit that AntiCancer brought against Xenogen in 2005. Caliper acquired Xenogen in 2006 (see IBO 2/15/06). Under the settlement, Caliper acquired the right to sublicense AntiCancer’s fluorescent protein optical imaging patents, and AntiCancer acquired […]
St. Louis, MO 3/7/08—Sigma-Aldrich and Oxford Biomedica have settled their patent litigation against Open Biosystems (see IBO 6/15/06). Under the confidential settlement, Open Biosystems will acquire certain license rights for use of Oxford BioMedica’s LentiVector gene delivery technology in research activities. Other details were not disclosed.
Billerica, MA and Hayward, CA 3/4/08—Milipore has announced that it will exclusively distribute Guava Technologies’ nonclinical flow cytometers within defined fields in North America, Europe and countries in Asia. Millipore will also provide field service and develop cobranded reagent kits. In addition, the companies will jointly develop new instruments.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
